FDA Biologics (BLA & Biosimilars)Original article
OTAT Town Hall: Gene Therapy Chemistry, Manufacturing, and Controls - 09/29/2022
Neutral
AI Analysis
Summary
The FDA's Office of Tissues and Advanced Therapies (OTAT) is hosting a virtual town hall to address stakeholder questions on gene therapy chemistry, manufacturing, and controls as the first in a series of informational events.
Importance:2/10
Sentiment:
0.00
Gene TherapyChemistry Manufacturing ControlsFDARegulatory GuidanceStakeholder Engagement
Related Companies
Read the original article
Published by FDA Biologics (BLA & Biosimilars) on September 9, 2026 6:48 PM